Amazon to launch online drug sales in Bengaluru to enhance reach

Amazon.com Inc said on Friday it will launch an online pharmacy in India that will serve the city of Bengaluru, the latest move by the e-commerce giant to widen its reach in a key growth market

Amazon,
Reuters BENGALURU
2 min read Last Updated : Aug 14 2020 | 11:50 AM IST

BENGALURU (Reuters) - Amazon.com Inc said on Friday it will launch an online pharmacy in India that will serve the city of Bengaluru, the latest move by the e-commerce giant to widen its reach in a key growth market.

The service, "Amazon Pharmacy", will offer both over-the-counter and prescription-based drugs, basic health devices and traditional Indian herbal medicines, the company said in a statement, without giving a timeline for the launch.

The move comes amid increasing competition in India with rivals Walmart-owned Flipkart, billionaire Mukesh Ambani's upstart online grocery service JioMart and a range of other smaller players.

Last month, the company decided to open 10 new warehouses in India and start offering auto insurance. Amazon had also secured clearance for alcohol delivery in one Indian state, Reuters reported in June.

India is yet to finalize regulations for online drug sales, or e-pharmacies, but the growth of several online sellers such as Medlife, Netmeds, Temasek-backed PharmEasy and Sequoia Capital-backed 1mg has threatened traditional drug stores.

The companies have said they comply with all Indian laws even as many trader groups continue to protest against e-pharmacies, saying that would lead to sale of medicines without proper verification.

"Amazon's customer base is very high, so we are bound to lose business. There are 5 million families dependent on this (offline) trade," Yash Aggarwal, legal head of South Chemists and Distributors Association in New Delhi, said on Friday.

The group will raise objections against Amazon's move with the government, he said.

 

(Reporting by Anuron Kumar Mitra in Bengaluru and Sankalp Phartiyal and Aditya Kalra in New Delhi; Editing by Arun Koyyur)

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Amazonpharmaceutical firmsBengaluru

First Published: Aug 14 2020 | 11:44 AM IST

Next Story